New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 7, 2014
16:18 EDTLXRXLexicon appoints Lonnel Coats as president, CEO
Lexicon Pharmaceuticals announced that Lonnel Coats has been appointed president and CEO effective July 7. Coats most recently served as president and CEO of Eisai Inc., the U.S. subsidiary of Eisai Co.
News For LXRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 4, 2015
09:08 EDTLXRXOn The Fly: Pre-market Movers
Subscribe for More Information
07:02 EDTLXRXLexicon reports Q4 EPS (0c), consensus (3c)
Subscribe for More Information
March 3, 2015
15:20 EDTLXRXNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include PetSmart (PETM), consensus $1.38... Trina Solar (TSL), consensus 13c... Lexicon Pharmaceuticals (LXRX), consensus (3c)... Abercrombie & Fitch (ANF), consensus $1.15... American Eagle Outfitters (AEO), consensus 34c... E. W. Scripps (SSP), consensus 40c.
March 2, 2015
07:20 EDTLXRXCowen to hold a conference
Subscribe for More Information
February 23, 2015
16:34 EDTLXRXLexicon Chief Scientific Officer resigns
Lexicon Pharmaceuticals announced the resignation of Brian Zambrowicz, Ph.D., executive vice president and Chief Scientific Officer, to pursue another opportunity. Dr. Zambrowicz will be assisting in shifting his responsibilities to other members of the company in order to ensure a seamless transition. In connection with the change, Lexicon will merge its discovery and clinical functions and conduct an immediate search for a head of research and development. Dr. Zambrowicz has agreed to be available to provide consulting services as the company completes this transition.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use